Fast-track assessment and rehabilitation for Stroke (FASTAR)
Completed
- Conditions
- Cardiovascular diseases: Cerebrovascular diseaseCirculatory SystemStroke
- Registration Number
- ISRCTN76357212
- Lead Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients admitted to North Manchester General Hospital or Stepping Hill within 48 hrs of onset of a new clinical diagnosis of stroke
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. All cause mortality<br>2. Functional Status<br>3. Length of hospital stay<br>4. Cause specific mortality<br>5. Morbidity<br>6. Time from admission to fit for discharge<br>7. Quality of life (patients and carers)
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie FASTAR's rehabilitation strategies for cerebrovascular disease?
How does FASTAR compare to standard-of-care rehabilitation in stroke recovery outcomes?
Are there specific biomarkers for patient selection in FASTAR stroke rehabilitation protocols?
What adverse events are associated with FASTAR's fast-track rehabilitation approach for stroke?
What combination therapies or drugs are being explored alongside FASTAR for cerebrovascular disease?